EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line

Mohamed Eleribi, Fakhri Elabbar, Basma Baaiu

AlQalam Journal of Medical and Applied Sciences · 30.05.2026

DOI: 10.54361/ajmas.269502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AlQalam Journal of Medical and Applied Sciences, online erschienen am 02.05.2026. Verfasst von Mohamed Eleribi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This investigation assesses the cytotoxic profiles and docking properties of twelve newly synthesized 1,3,4-thiadiazole derivatives against the MCF-7 cell line. The results revealed that nine of these compounds displayed noteworthy cytotoxic activity, with the most effective compound recording an IC50 value of 17.30 μM. Additionally, docking analyses indicated binding energies ranging from (-7.6 to -12.4 kcal/mol). In silico evaluations confirmed that all compounds are in alignment with Lipinski's Rule of Five. Moreover, the ADMET properties suggest that these synthesized derivatives are suitable for oral administration.

Zitieren

APA

Eleribi, M., Elabbar, F., & Baaiu, B. (2026). Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line. AlQalam Journal of Medical and Applied Sciences. https://doi.org/10.54361/ajmas.269502

Vancouver

Eleribi M, Elabbar F, Baaiu B. Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line. AlQalam Journal of Medical and Applied Sciences. 2026. doi:10.54361/ajmas.269502

BibTeX
@article{Eleribi2026,
  author = {Eleribi, Mohamed and Elabbar, Fakhri and Baaiu, Basma},
  title = {Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line},
  journal = {AlQalam Journal of Medical and Applied Sciences},
  year = {2026},
  doi = {10.54361/ajmas.269502}
}
Kostenlos starten →